S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
NASDAQ:SGRY

Surgery Partners (SGRY) Stock Forecast, Price & News

$39.78
+1.62 (+4.25%)
(As of 06/2/2023 ET)
Compare
Today's Range
$39.24
$40.53
50-Day Range
$31.36
$40.35
52-Week Range
$20.46
$41.80
Volume
925,538 shs
Average Volume
630,633 shs
Market Capitalization
$5.03 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$43.27

Surgery Partners MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.78 Rating Score
Upside/​Downside
10.8% Upside
$44.09 Price Target
Short Interest
Bearish
7.95% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.95mentions of Surgery Partners in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$1.59 M Sold Last Quarter
Proj. Earnings Growth
90.32%
From $0.31 to $0.59 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.74 out of 5 stars

Medical Sector

778th out of 983 stocks

General Medical & Surgical Hospitals Industry

5th out of 5 stocks


SGRY stock logo

About Surgery Partners (NASDAQ:SGRY) Stock

Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.

Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

SGRY Stock News Headlines

[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software"
The Washington Post Reports it's: "A revolution in warfare." The Sunday Times Reports it's: "a revolutionary power." Early investors can reap 5,633% gains as England, Germany, Japan and Australia rush to sign contracts. Get the name of the stock here >>>
Surgery Partners (NASDAQ:SGRY) Upgraded at Bank of America
Famous Wall Street Crash System Flashes RED
Hundreds of banks, hedge funds, and brokerages have paid $5,000 a month to access these alerts. Because when this system flashes on U.S. stocks, huge gains – and losses – can follow.
Q1 2023 Surgery Partners Inc Earnings Call
Surgery Partners earnings: here's what Wall Street expects
Surgery Partners (SGRY) Scheduled to Post Earnings on Monday
How Much Does Cataract Surgery Cost?
See More Headlines

SGRY Price History

SGRY Company Calendar

Last Earnings
5/01/2023
Today
6/02/2023
Next Earnings (Estimated)
8/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
General medical & surgical hospitals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SGRY
Employees
12,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$44.09
High Stock Price Forecast
$56.00
Low Stock Price Forecast
$35.00
Forecasted Upside/Downside
+7.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.78
Research Coverage
9 Analysts

Profitability

Net Income
$-54,600,000.00
Pretax Margin
2.52%

Debt

Sales & Book Value

Annual Sales
$2.54 billion
Cash Flow
$0.96 per share
Book Value
$23.26 per share

Miscellaneous

Free Float
122,303,000
Market Cap
$5.12 billion
Optionable
Optionable
Beta
2.75

Key Executives

  • J. Eric EvansJ. Eric Evans
    Chief Executive Officer & Director
  • David T. DohertyDavid T. Doherty
    Chief Financial Officer & Executive Vice President
  • Varun Gadhok
    Chief Information Officer & Senior Vice President
  • Roxanne Womack
    Chief Compliance Officer & Senior Vice President
  • Jennifer B. BaldockJennifer B. Baldock
    Secretary, Chief Administrative Officer & EVP













SGRY Stock - Frequently Asked Questions

Should I buy or sell Surgery Partners stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last twelve months. There are currently 1 hold rating and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SGRY shares.
View SGRY analyst ratings
or view top-rated stocks.

What is Surgery Partners' stock price forecast for 2023?

9 brokers have issued 1-year target prices for Surgery Partners' shares. Their SGRY share price forecasts range from $35.00 to $56.00. On average, they predict the company's share price to reach $44.09 in the next twelve months. This suggests a possible upside of 9.0% from the stock's current price.
View analysts price targets for SGRY
or view top-rated stocks among Wall Street analysts.

How have SGRY shares performed in 2023?

Surgery Partners' stock was trading at $27.86 at the start of the year. Since then, SGRY shares have increased by 45.2% and is now trading at $40.45.
View the best growth stocks for 2023 here
.

When is Surgery Partners' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023.
View our SGRY earnings forecast
.

How were Surgery Partners' earnings last quarter?

Surgery Partners, Inc. (NASDAQ:SGRY) announced its quarterly earnings results on Monday, May, 1st. The company reported $0.05 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.09. The business had revenue of $666.20 million for the quarter, compared to the consensus estimate of $644.16 million. Surgery Partners had a negative net margin of 3.51% and a positive trailing twelve-month return on equity of 0.59%.

What is Eric Evans' approval rating as Surgery Partners' CEO?

7 employees have rated Surgery Partners Chief Executive Officer Eric Evans on Glassdoor.com. Eric Evans has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Surgery Partners own?
What is Surgery Partners' stock symbol?

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

Who are Surgery Partners' major shareholders?

Surgery Partners' stock is owned by a variety of retail and institutional investors. Top institutional investors include FMR LLC (14.95%), Wellington Management Group LLP (5.49%), Clearbridge Investments LLC (4.40%), BlackRock Inc. (3.01%), State Street Corp (0.99%) and Geode Capital Management LLC (0.96%). Insiders that own company stock include Anthony Taparo, Bradley R Owens, Brent Turner, Danielle Burkhalter, David T Doherty, George Goodwin, Jason Eric Evans, Jennifer Baldock, Laura L Brocklehurst, Laura L Brocklehurst, Marissa Brittenham, Teresa Deluca, Thomas F Cowhey and Wayne S Deveydt.
View institutional ownership trends
.

How do I buy shares of Surgery Partners?

Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Surgery Partners' stock price today?

One share of SGRY stock can currently be purchased for approximately $40.45.

How much money does Surgery Partners make?

Surgery Partners (NASDAQ:SGRY) has a market capitalization of $5.12 billion and generates $2.54 billion in revenue each year. The company earns $-54,600,000.00 in net income (profit) each year or ($0.92) on an earnings per share basis.

How many employees does Surgery Partners have?

The company employs 12,200 workers across the globe.

How can I contact Surgery Partners?

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The official website for the company is www.surgerypartners.com. The company can be reached via phone at (615) 234-5900, via email at ir@surgerypartners.com, or via fax at 615-234-5998.

This page (NASDAQ:SGRY) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -